Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-060910

Director bought 3,000 shares at an average $16.88 ($50,633)

From the SEC's structured data for this filing

Trades in this filing

Kaplan Matthew L. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-12 Purchase : show line 1 in the form +1,177 $15.96 $18,785 33,937 D
2022-05-12 Purchase : show line 2 in the form +1,823 $17.47 $31,848 35,760 D
Open-market purchases · 3,000 sh · avg $16.88 · $50,633
Loading xslF345X03/tm2215423d2_4.xml…